EP0208855B1
(de)
*
|
1985-05-13 |
1991-03-06 |
Schering Corporation |
Verfahren zur Herstellung von Piperidyliden-dihydrodibenzo(a,d)zykloheptenen und deren Azoderivate, so hergestellte Verbindungen und ihre Anwendung zur Vorbereitung von Heilmitteln
|
US4804666A
(en)
*
|
1985-08-14 |
1989-02-14 |
Schering Corporation |
Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines
|
US4873335A
(en)
*
|
1986-03-12 |
1989-10-10 |
Schering Corporation |
3-phenethyl-2-benzene-amides or aza-derivatives thereof
|
US5665726A
(en)
*
|
1986-10-31 |
1997-09-09 |
Schering Corporation |
Benzo[5,6]cycloheptapyridines, compositions and methods of use
|
US4826853A
(en)
*
|
1986-10-31 |
1989-05-02 |
Schering Corporation |
6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
|
US5438062A
(en)
*
|
1986-10-31 |
1995-08-01 |
Schering Corporation |
Benzo(5,6)cycloheptapyridines, compositions and methods of use
|
US5089496A
(en)
*
|
1986-10-31 |
1992-02-18 |
Schering Corporation |
Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
|
NZ228888A
(en)
*
|
1988-04-28 |
1991-12-23 |
Schering Corp |
Derivatives of piperidine, piperidylidene and piperazine and pharmaceutical compositions
|
US4910205A
(en)
*
|
1988-05-02 |
1990-03-20 |
Schering Corporation |
Transdermal delivery of loratadine
|
US4990535A
(en)
*
|
1989-05-03 |
1991-02-05 |
Schering Corporation |
Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
|
IE68935B1
(en)
*
|
1990-06-22 |
1996-07-24 |
Schering Corp |
Bis-benzo or benzopyrido cyclohepta piperidene piperidylidene and piperazine compounds compositions and methods of use
|
ES2040177B1
(es)
*
|
1992-03-06 |
1994-05-16 |
S A Tamarang |
Procedimiento para la sintesis de la 8-cloro-6, 11-dihidro-11, (1-etoxicarbonil-4-piperidiliden) -5h-benzo (5,6) ciclohepta-(1,2-b) piridina.
|
HUT71132A
(en)
*
|
1992-03-27 |
1995-11-28 |
Schering Corp |
Bis-aryl-carbinol derivatives, pharmaceutical compositions containing them and process for producing
|
ATE140224T1
(de)
*
|
1992-03-27 |
1996-07-15 |
Schering Corp |
Unverbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung
|
ES2042421B1
(es)
*
|
1992-05-22 |
1994-08-01 |
Uriach & Cia Sa J |
Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
|
US5631365A
(en)
|
1993-09-21 |
1997-05-20 |
Schering Corporation |
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
|
US5595997A
(en)
*
|
1994-12-30 |
1997-01-21 |
Sepracor Inc. |
Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
|
US7211582B1
(en)
|
1994-12-30 |
2007-05-01 |
Sepracor Inc. |
Methods for treating urticaria using descarboethoxyloratadine
|
US7214683B1
(en)
|
1994-12-30 |
2007-05-08 |
Sepracor Inc. |
Compositions of descarboethoxyloratadine
|
TW522014B
(en)
*
|
1997-02-07 |
2003-03-01 |
Sepracor Inc |
Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
|
US5900421A
(en)
*
|
1997-02-11 |
1999-05-04 |
Sepracor Inc. |
Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
|
US5939426A
(en)
*
|
1997-02-28 |
1999-08-17 |
Sepracor Inc. |
Methods for treating urinary incontinence using descarboethoxyloratadine
|
US5998620A
(en)
*
|
1997-03-25 |
1999-12-07 |
Schering Corporation |
Synthesis of intermediates useful in preparing tricyclic compounds
|
ATE220546T1
(de)
*
|
1997-04-25 |
2002-08-15 |
Schering Plough Kabushiki Kais |
Augentropfen enthaltend ein loratidinmetabolit
|
US6506767B1
(en)
|
1997-07-02 |
2003-01-14 |
Schering Corporation |
8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
|
UA62976C2
(en)
*
|
1997-07-02 |
2004-01-15 |
Schering Corp |
Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
|
US6140337A
(en)
|
1997-12-23 |
2000-10-31 |
Schering Corporation |
Methods for the treatment of mental disorders
|
US6132758A
(en)
*
|
1998-06-01 |
2000-10-17 |
Schering Corporation |
Stabilized antihistamine syrup
|
DE69919789T2
(de)
*
|
1998-06-30 |
2005-09-08 |
Pfizer Products Inc., Groton |
Loratadin zur Verwendung als Antiarrhythmikum
|
CN1145485C
(zh)
*
|
1998-07-10 |
2004-04-14 |
先灵公司 |
8-氯-6,11-二氢-11-(4-亚哌啶基)-5H-苯并[5,6]环庚三烯并[1,2-b]吡啶口服组合物
|
US6423721B1
(en)
|
1998-09-10 |
2002-07-23 |
Schering Corporation |
Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
|
US6271378B1
(en)
|
1998-12-18 |
2001-08-07 |
Schering Corporation |
Process for preparing tricyclic compounds having antihistaminic activity
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6100274A
(en)
*
|
1999-07-07 |
2000-08-08 |
Schering Corporation |
8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
|
NZ517465A
(en)
|
1999-09-02 |
2003-10-31 |
Nostrum Pharmaceuticals Inc |
Controlled release pellet formulation
|
WO2001021161A2
(en)
*
|
1999-09-21 |
2001-03-29 |
Schering Corporation |
Use of desloratadine for treating allergic and inflammatory conditions
|
AU7589700A
(en)
*
|
1999-09-22 |
2001-04-24 |
Schering Corporation |
Treating allergic and inflammatory conditions
|
US6114346A
(en)
|
1999-10-22 |
2000-09-05 |
Schering Corporation |
Treating sleep disorders using desloratadine
|
AU2276801A
(en)
|
1999-12-20 |
2001-07-03 |
Schering Corporation |
Extended release oral dosage composition
|
AU2277101A
(en)
|
1999-12-20 |
2001-07-03 |
Schering Corporation |
Stable extended release oral dosage composition
|
US7405223B2
(en)
|
2000-02-03 |
2008-07-29 |
Schering Corporation |
Treating allergic and inflammatory conditions
|
MXPA02007558A
(es)
*
|
2000-02-03 |
2002-12-13 |
Schering Corp |
Tratamiento de condiciones inflamatorias alergicas.
|
DE60141596D1
(de)
*
|
2000-10-23 |
2010-04-29 |
Euro Celtique Sa |
Transdermales system zur verabreichung von loratadin und dessen verwendung
|
WO2002036077A2
(en)
*
|
2000-11-06 |
2002-05-10 |
Andrx Pharmaceuticals, Inc. |
Once a day antihistamine and decongestant formulation
|
HU226998B1
(en)
|
2000-11-23 |
2010-04-28 |
Richter Gedeon Nyrt |
Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same
|
WO2002058610A1
(en)
*
|
2001-01-24 |
2002-08-01 |
Summanus Pharma, Inc. |
Alkyl aryl polyether alcohol polymers for improvement of nasal breathing
|
US20020177608A1
(en)
*
|
2001-04-09 |
2002-11-28 |
Ben-Zion Dolitzky |
Polymorphs of fexofenadine hydrochloride
|
US20030021849A1
(en)
*
|
2001-04-09 |
2003-01-30 |
Ben-Zion Dolitzky |
Polymorphs of fexofenadine hydrochloride
|
US6599913B1
(en)
*
|
2001-06-29 |
2003-07-29 |
Schering Corporation |
Treating allergic and inflammatory conditions
|
US6720002B2
(en)
*
|
2001-07-20 |
2004-04-13 |
R.P. Scherer Technologies, Inc. |
Antihistamine formulations for soft capsule dosage forms
|
MXPA04001608A
(es)
|
2001-08-21 |
2004-07-08 |
Schering Corp |
Un procedimiento de sintesis de un intermediario de cetona triciclica.
|
WO2003086275A2
(en)
*
|
2002-04-15 |
2003-10-23 |
Sun Pharmaceutical Industries Limited |
Preperation of desloratatine
|
US20030004179A1
(en)
*
|
2002-05-21 |
2003-01-02 |
Affrime Melton B |
Treating allergic and inflammatory conditions
|
AU2003248657A1
(en)
*
|
2002-06-10 |
2003-12-22 |
Teva Pharmaceutical Industries Ltd. |
Polymorphic form xvi of fexofenadine hydrochloride
|
US20040001885A1
(en)
*
|
2002-06-27 |
2004-01-01 |
Unchalee Kositprapa |
Rapidly disintegrating antihistamine formulation
|
GB0216383D0
(en)
*
|
2002-07-13 |
2002-08-21 |
Astrazeneca Ab |
Compounds
|
EP1539161A1
(de)
*
|
2002-08-05 |
2005-06-15 |
Sandoz AG |
Neues salz und polymorphe von desloratadinhemifumarat
|
JP2006505590A
(ja)
*
|
2002-10-23 |
2006-02-16 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ヒスタミンh3受容体調節物質としてのフェニルピペリジンおよびフェニルピロリジン
|
US8092831B2
(en)
*
|
2002-11-08 |
2012-01-10 |
Andrx Pharmaceuticals, Llc |
Antihistamine and decongestant system
|
US20040242619A1
(en)
*
|
2003-03-12 |
2004-12-02 |
Toth Zoltan G. |
Processes for preparation of polymorphic forms of desloratadine
|
US20060135547A1
(en)
*
|
2003-03-12 |
2006-06-22 |
Toth Zoltan G |
Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
|
WO2004080997A1
(en)
*
|
2003-03-13 |
2004-09-23 |
Morepen Laboratories Limited |
Process for the preparation of loratadine
|
JP2007532687A
(ja)
*
|
2004-04-26 |
2007-11-15 |
テバ ファーマシューティカル インダストリーズ リミティド |
フェキソフェナジン塩酸塩の結晶形およびその製造方法
|
EA011894B1
(ru)
*
|
2004-07-07 |
2009-06-30 |
Эгиш Дьёдьсердьяр Нирт. |
Новая псевдополиморфная форма деслоратадина, образованная с диоксидом углерода
|
WO2006006184A2
(en)
*
|
2004-07-08 |
2006-01-19 |
Morepen Laboratories Limited |
A process for the manufacturing of loratadine and its intermediates
|
NL1026634C2
(nl)
*
|
2004-07-12 |
2006-01-16 |
Willem Jacob Van Der Burg |
Psychofarmaceutisch preparaat en werkzame stof daarin.
|
AU2005263958B2
(en)
*
|
2004-07-16 |
2011-04-14 |
Cipla Limited |
Anti-histaminic composition
|
CA2575932A1
(en)
*
|
2004-08-04 |
2006-02-16 |
Schering Corporation |
Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
|
JP2008514641A
(ja)
*
|
2004-09-28 |
2008-05-08 |
テバ ファーマシューティカル インダストリーズ リミティド |
結晶形フェキソフェナジン、およびその調製方法
|
US20070009558A1
(en)
*
|
2004-12-22 |
2007-01-11 |
David Harris |
Sugar-free storage-stable antihistaminic syrups
|
US20070004671A1
(en)
*
|
2005-05-20 |
2007-01-04 |
Agarwal Sudeep K |
Stable desloratadine compositions
|
US20070060756A1
(en)
*
|
2005-08-11 |
2007-03-15 |
Orchid Chemicals & Pharmaceuticals Ltd. |
Process for the preparation of desloratadine
|
US20070036859A1
(en)
*
|
2005-08-11 |
2007-02-15 |
Perry Ronald L |
Sustained release antihistamine and decongestant composition
|
US20070135472A1
(en)
*
|
2005-12-01 |
2007-06-14 |
Glenmark Pharmaceuticals Limited |
Novel crystalline forms of desloratadine and processes for their preparation
|
CA2541045A1
(en)
*
|
2006-03-24 |
2007-09-24 |
Pharmascience Inc. |
A descarbonylethoxyloratadine containing pharmaceutical composition
|
EP2034970B1
(de)
*
|
2006-06-01 |
2012-08-01 |
MSD Consumer Care, Inc. |
Phenylephrin enthaltende pharmazeutische formulierung mit verzögerter freisetzung
|
TWI405567B
(zh)
*
|
2006-06-01 |
2013-08-21 |
Merck Sharp & Dohme |
持續釋放脫羥腎上腺素之醫藥組合物
|
EP2023957A2
(de)
*
|
2006-06-07 |
2009-02-18 |
Morton Grove Pharmaceuticals, Inc. |
Orale flüssige loratadinformulierungen und verfahren
|
HU230417B1
(hu)
*
|
2006-10-26 |
2016-05-30 |
Egis Gyógyszergyár Zrt |
Eljárás desloratadine szén-dioxiddal képezett adduktjának előállítására
|
WO2008107777A2
(en)
*
|
2007-03-06 |
2008-09-12 |
Cadila Pharmaceuticals Limited |
Improved method for the preparation of desloratadine with reduced levels of organic solvents
|
WO2009020620A1
(en)
*
|
2007-08-06 |
2009-02-12 |
Bridge Pharma, Inc. |
Synergisms between repartitioning and immunomodulating compounds
|
US20090082385A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched desloratidine
|
WO2010021681A2
(en)
*
|
2008-08-18 |
2010-02-25 |
Combinatorx (Singapore) Pte. Ltd. |
Compositions and methods for treatment of viral diseases
|
TR200806298A2
(tr)
|
2008-08-22 |
2010-03-22 |
Bi̇lgi̇ç Mahmut |
Farmasötik formülasyon
|
EP2411380A1
(de)
*
|
2009-03-26 |
2012-02-01 |
Ranbaxy Laboratories Limited |
Verfahren zur herstellung von desloratadin
|
TW201111392A
(en)
|
2009-06-16 |
2011-04-01 |
Schering Corp |
Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof
|
EP2269586B1
(de)
|
2009-07-01 |
2011-09-21 |
Alfred E. Tiefenbacher (GmbH & Co. KG) |
Pharmazeutische Zusammensetzung mit Desloratadin
|
CA2690490C
(en)
|
2010-01-19 |
2012-06-26 |
Accucaps Industries Limited |
Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
|
WO2011146030A2
(en)
|
2010-05-18 |
2011-11-24 |
Mahmut Bilgic |
Effervescent antihistamine formulations
|
DE102010044246B4
(de)
|
2010-09-02 |
2015-06-25 |
Johnson Controls Gmbh |
Kopfstütze mit zwei Flügelelementen und Verfahren zur Montage eines Flügelelementes
|
TR201007652A2
(tr)
|
2010-09-20 |
2012-04-24 |
Bi̇lgi̇ç Mahmut |
Sinerjik etki.
|
TR201009396A2
(tr)
|
2010-11-11 |
2012-05-21 |
Bi̇lgi̇ç Mahmut |
Desloratadin granüller
|
US8778971B2
(en)
|
2012-10-23 |
2014-07-15 |
Bridge Pharma, Inc. |
Medicinal treatment of dermal diseases in companion animals
|
US8557846B1
(en)
|
2012-10-23 |
2013-10-15 |
Bridge Pharma, Inc. |
Medicinal treatment of dermal diseases in dogs
|
US20140120121A1
(en)
|
2012-10-30 |
2014-05-01 |
Bridge Pharma, Inc. |
Medicinal treatment of atopic inflammatory diseases
|
US20150272941A1
(en)
|
2012-10-30 |
2015-10-01 |
Bridge Pharma, Inc. |
Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifen
|
US9138431B2
(en)
|
2013-08-06 |
2015-09-22 |
Bridge Pharma, Inc. |
Methods of treatment of histamine H-4 receptor-related pruritus
|
US10525057B2
(en)
|
2013-09-24 |
2020-01-07 |
Otsuka Pharmaceutical Co., Ltd. |
Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
|
CN104961724B
(zh)
*
|
2015-06-08 |
2018-01-30 |
惠州信立泰药业有限公司 |
一种获得高纯度地氯雷他定的先进生产工艺
|
RU2631619C2
(ru)
*
|
2015-08-03 |
2017-09-25 |
Общество с ограниченной ответственностью "Трейдсервис" |
Диспергируемая в воде таблетка дезлоратадина и способ ее изготовления
|
CN107400083A
(zh)
*
|
2017-08-28 |
2017-11-28 |
四川大学 |
一种3‑[2‑(3‑氯苯基)乙基]‑2‑吡啶甲腈的制备方法
|
CN107556237B
(zh)
*
|
2017-08-28 |
2020-11-24 |
四川大学 |
一种3-(2-苯乙基)-2-吡啶甲酰胺类化合物的制备方法
|
MX2022015335A
(es)
|
2020-12-04 |
2023-01-11 |
Laboratorios Silanes S A De C V |
Combinacion farmaceutica de un corticosteroide y un antihistaminico para el tratamiento y control del componente inflamatorio de procesos alergicos.
|
CN112898268A
(zh)
*
|
2021-04-07 |
2021-06-04 |
深圳振强生物技术有限公司 |
一种地氯雷他定杂质的制备方法
|